Careers

Agios is a biopharmaceutical company passionately committed to applying our scientific leadership in the field of cellular metabolism to transform the lives of patients with cancer and inborn errors of metabolism.
NASDAQ: AGIO$46.34 Stock is Down 1.2 (2.52%)

UPCOMING EVENTS

Read more
There are currently no events scheduled.

CONTACTS

Media Inquiries:
Dan Budwick
Pure Communications
973-271-6085

Investor Inquiries:
investors@agios.com